Nurix TherapeuticsNRIX 
$24.74-0.36%24h
-0.36%24h
Global rank7040
Market cap$1.20B
Change 7d5.14%
YTD Performance138.57%
SP500 benchmarkOutperform
P/E0
P/S15.59
Revenue$76.99M
Earnings-$143.95M
Dividend yield-
EPS for Nurix Therapeutics (NRIX)
Nurix Therapeutics has an EPS of $-3.71. In 2021, the company made an earnings per share (EPS) of $-2.73. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NRIX
-
Value:-
EPS history for Nurix Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$3.71 | 35.90% |
| 2021 | -$2.73 | -1.09% |
| 2020 | -$2.76 | - |
View the highest EPS stocks
